Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Consolidated Net Income (2020 - 2025)

RxSight (RXST) has disclosed Consolidated Net Income for 6 consecutive years, with $29.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Consolidated Net Income rose 600.49% year-over-year to $29.7 million, compared with a TTM value of -$67000.0 through Dec 2025, up 99.76%, and an annual FY2025 reading of -$67000.0, up 99.76% over the prior year.
  • Consolidated Net Income was $29.7 million for Q4 2025 at RxSight, up from -$9.8 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $29.7 million in Q4 2025 and bottomed at -$17.6 million in Q1 2022.
  • Average Consolidated Net Income over 5 years is -$9.6 million, with a median of -$12.1 million recorded in 2023.
  • The sharpest move saw Consolidated Net Income plummeted 158.57% in 2022, then surged 600.49% in 2025.
  • Year by year, Consolidated Net Income stood at -$15.7 million in 2021, then increased by 0.86% to -$15.6 million in 2022, then soared by 41.21% to -$9.2 million in 2023, then soared by 35.3% to -$5.9 million in 2024, then soared by 600.49% to $29.7 million in 2025.
  • Business Quant data shows Consolidated Net Income for RXST at $29.7 million in Q4 2025, -$9.8 million in Q3 2025, and -$11.8 million in Q2 2025.